Self-contained, eye-safe hair-regrowth-inhibition apparatus and method
A dermatologic hair-regrowth-inhibiting apparatus is disclosed which is cordless and sufficiently compact as to be hand-held. A self-contained housing is configured for gripping by a person's hand for cordless manipulation in a hair-regrowth-inhibiting procedure. A light source and electrical circuit are contained within the housing. The circuit includes one or more batteries for energizing the light source to produce output light pulses. A light path within the housing includes an aperture through which eye-safe light pulses are propagated out of the housing having properties sufficient for at least temporary hair-regrowth inhibition. A diffuser is disposed along the light path to reduce the integrated radiance to an eye-safe level.
1. A dermatologic treatment apparatus, comprising:
a pulsed laser light source that emits coherent, divergent light;
an output end configured to be placed against the skin; and
an optical system including an optical diffuser arranged to receive the coherent light from the pulsed laser light source and diffuse the coherent light to provide a series of diffuse light pulses;
wherein the optical system is configured to emit the diffuse light pulses from the output end of the apparatus at a fluence of 4-100 J/cm 2 for delivery to the skin to effect a hair removal or hair-regrowth-inhibiting dermatological treatment; and
wherein the diffuse light pulses emitted from the output end of the apparatus have a pulse duration t of less than 10 seconds, and an integrated radiance in Jcm −2 sr −1 less than 10t 1/3 when the wavelength of the light is 600 to 700 nm, less than 10*10 (λ-700)/515 t 1/3 when the wavelength λ of the light is 700 to 1060 nm, and less than 50t 1/3 when the wavelength of the light is 1060 to 1200 nm, and are thus eye safe during the dermatological treatment.
2. The apparatus of claim 1 , wherein the pulsed laser light source comprises one or more laser diode bars.
3. The apparatus of claim 1 , wherein the pulsed laser light source comprises one or more diode lasers.
4. The apparatus of claim 1 , wherein the diffuse light pulses emitted from the output end of the apparatus qualify as Class 1 eye safe under International Standard IEC 60825.1.
5. The apparatus of claim 1 , wherein the diffuse light pulses emitted from the output end of the apparatus qualify as Class 1 eye safe under the standards set forth in in 21 C.F.R. 1040.10.
6. The apparatus of claim 1 , wherein the coherent light emitted by the pulsed laser light source is primarily within a spectral band of 700 nm to 1100 nm.
7. The apparatus of claim 1 , wherein the optical diffuser comprises a transmissive bulk diffuser.
8. A dermatologic treatment apparatus, comprising:
a pulsed laser light source that emits coherent light;
an output end configured to be placed against the skin; and
an optical system including an optical diffuser arranged to receive the coherent light from the pulsed laser light source and diffuse the coherent light to provide diffuse light pulses;
wherein the optical system is configured to emit the diffuse light pulses from the output end of the apparatus at a fluence of 4-100 J/cm 2 for delivery to the skin to effect a hair removal or hair-regrowth-inhibiting dermatological treatment;
wherein the diffuse light pulses emitted from the output end of the apparatus have a duration t of between 100 ms and 1 sec, and an integrated radiance in Jcm −2 sr −1 less than 10t 1/3 when the wavelength of the light is 600 to 700 nm, less than 10*10 (λ-700)/515 t 1/3 when the wavelength λ of the light is 700 to 1060 nm, and less than 50t 1/3 when the wavelength of the light is 1060 to 1200 nm, and are thus eye safe during the dermatological treatment; and
wherein the optical system distributes coherent light from the laser light source uniformly across an input of the diffuser.
9. The apparatus of claim 8 , wherein the optical system includes a mixer configured to uniformly distribute light from the laser light source across an input of the diffuser.
10. A dermatologic treatment apparatus, comprising:
a pulsed laser light source that emits coherent light, wherein the laser light source is pulsed with a pulse duration t of between 10 ms and 1 sec;
an output end configured to be placed against the skin; and
an optical system including an optical diffuser arranged to receive the coherent light from the pulsed laser light source and diffuse the coherent light to provide diffuse light pulses;
wherein the optical system is configured to emit the diffuse light pulses from the output end of the apparatus at a fluence of 4-100 J/cm 2 for delivery to the skin to effect a hair removal or hair-regrowth-inhibiting dermatological treatment; and
wherein the diffuse light pulses emitted from the output end of the apparatus have an integrated radiance in Jcm −2 sr −1 less than 10t 1/3 when the wavelength of the light is 600 to 700 nm, less than 10*10 (λ-700)/515 t 1/3 when the wavelength λ of the light is 700 to 1060 nm, and less than 50t 1/3 when the wavelength of the light is 1060 to 1200 nm, and are thus eye safe during the dermatological treatment.
11. The apparatus of claim 10 , wherein the laser light source is pulsed with a pulse duration of between 100 ms and 500 ms.
12. A dermatologic treatment apparatus, comprising:
a pulsed laser device that emits coherent, divergent laser radiation;
an output end configured to be placed against the skin; and
an optical system including an optical diffuser downstream of the pulsed laser device and configured to diffuse the coherent laser radiation to provide diffuse laser radiation pulses;
wherein the optical system is configured to emit the diffuse laser radiation pulses from the output end of the apparatus at a fluence of 4-100 J/cm 2 for delivery to the skin to effect a dermatological treatment; and
wherein the diffuse laser radiation pulses emitted from the output end of the apparatus have a pulse duration t and an integrated radiance in Jcm −2 sr −1 less than 10t 1/3 when the wavelength of the laser radiation is 600 to 700 nm, less than 10*10 (λ-700)/515 t 1/3 when the wavelength λ of the laser radiation is 700 to 1060 nm, and less than 50t 1/3 when the wavelength of the laser radiation is 1060 to 1200 nm where t is less than 10 seconds, and are thus eye safe during the dermatological treatment.
13. The apparatus of claim 12 , wherein the optical system distributes coherent laser radiation from the laser device uniformly across an input of the diffuser.
14. The apparatus of claim 12 , wherein the optical system includes a mixer configured to uniformly distribute the laser radiation from the laser device across an input of the diffuser.
15. The apparatus of claim 12 , wherein the laser device comprises one or more laser diode bars.
16. The apparatus of claim 12 , wherein the laser device comprises one or more diode lasers.
17. The apparatus of claim 12 , wherein the diffuse laser radiation emitted from the output end of the apparatus qualifies as Class 1 eye safe under International Standard IEC 60825.1.
18. The apparatus of claim 12 , wherein the diffuse laser radiation emitted from the output end of the apparatus qualifies as Class 1 eye safe under the standards set forth in in 21 C.F.R. 1040.10.
19. A dermatologic treatment apparatus, comprising:
a housing configured to be handheld;
an output end configured to be placed against the skin;
a laser light source configured to emit coherent light;
a direct drive electrical circuit disposed within the housing, the direct drive electrical circuit comprising one or more batteries that energize the laser light source to produce a light pulse of coherent light, the electrical circuit configured such that during the coherent light pulse the instantaneous current flow through the one or more batteries is substantially equal to the total instantaneous current flow through the laser light source; and
an optical system including an optical diffuser arranged to receive the coherent light pulse from the laser light source and diffuse the coherent light to provide a diffuse light pulse;
wherein the optical system is configured to emit the diffuse light pulse from the output end of the apparatus at a fluence of 4-100 J/cm 2 for delivery to the skin; and
wherein the diffuse light pulse emitted from the output end of the apparatus is eye safe during the dermatological treatment.